This induced pluripotent stem (iPS) cell line, which serves as a model for Fragile X Syndrome (FXS), was created by reprogramming a FXS fibroblast line from an 8 year old male. The cell line is a full mutation FXS iPS cell line that lacks FMR1 and FMRP expression consistent with FXS diagnosis.
Cell Line Alias FX13-2
Cell Type Human iPS
Disease Fragile X syndrome
Genetic Alteration/Mutation FMR1
Sex Male  
Age at Collection 8 years
Genetically Related Cell Lines  
Reprogramming Method Viral transfection (Lentivirus: Oct4, Klf4, Sox2, cMyc)
Provider University of Wisconsin - Dr. Anita Bhattacharyya
dbGaP Data  
Eagle-I UID  
hPSCReg ID  
NIH Approval  
Pub Med Abstract  
Related Products
Have you received this cell line previously? Yes No Why we ask
Quantity: Learn about our volume discounts

Current Lot Information

Lot Number Culture Platform Lot Description Passage Number Banked By Protocol Product Information & Testing
WB16523 Stem Cell Culture Medium (KOSR/MEF) 16 WiCell WiCell Feeder Dependent Protocol PDF